Zura Bio Limited Stock Buy Hold or Sell Recommendation
| ZURA Stock | 2.92 0.00 0.00% |
Given the investment horizon of 90 days and your conservative risk appetite, our recommendation regarding Zura Bio Limited is 'Strong Sell'. Macroaxis provides Zura Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Zura Bio positions.
Check out Zura Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Zura and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Zura Bio Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Zura |
Execute Zura Bio Buy or Sell Advice
The Zura recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Zura Bio Limited. Macroaxis does not own or have any residual interests in Zura Bio Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Zura Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Zura Bio Trading Alerts and Improvement Suggestions
| Zura Bio Limited generated a negative expected return over the last 90 days | |
| Zura Bio Limited has high historical volatility and very poor performance | |
| Net Loss for the year was (60.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zura Bio generates negative cash flow from operations | |
| Zura Bio Limited has a poor financial position based on the latest SEC disclosures | |
| About 32.0% of the company outstanding shares are owned by insiders | |
| Latest headline from thelincolnianonline.com: HC Wainwright Reaffirms Neutral Rating for Zura Bio |
Zura Bio Returns Distribution Density
The distribution of Zura Bio's historical returns is an attempt to chart the uncertainty of Zura Bio's future price movements. The chart of the probability distribution of Zura Bio daily returns describes the distribution of returns around its average expected value. We use Zura Bio Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Zura Bio returns is essential to provide solid investment advice for Zura Bio.
| Mean Return | -0.18 | Value At Risk | -7.94 | Potential Upside | 7.95 | Standard Deviation | 5.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Zura Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Zura Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Zura Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Zura Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Zura stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.36 | |
β | Beta against Dow Jones | 2.06 | |
σ | Overall volatility | 4.86 | |
Ir | Information ratio | -0.05 |
Zura Bio Volatility Alert
Zura Bio Limited exhibits very low volatility with skewness of -0.46 and kurtosis of 1.79. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Zura Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Zura Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Zura Bio Fundamentals Vs Peers
Comparing Zura Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Zura Bio's direct or indirect competition across all of the common fundamentals between Zura Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Zura Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Zura Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Zura Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Zura Bio to competition |
| Fundamentals | Zura Bio | Peer Average |
| Return On Equity | -0.37 | -0.31 |
| Return On Asset | -0.21 | -0.14 |
| Current Valuation | 189.69 M | 16.62 B |
| Shares Outstanding | 63.77 M | 571.82 M |
| Shares Owned By Insiders | 31.87 % | 10.09 % |
| Shares Owned By Institutions | 53.29 % | 39.21 % |
| Number Of Shares Shorted | 1.75 M | 4.71 M |
| Price To Book | 1.24 X | 9.51 X |
| EBITDA | (60.56 M) | 3.9 B |
| Net Income | (60.56 M) | 570.98 M |
| Total Debt | 21.29 M | 5.32 B |
| Book Value Per Share | 2.34 X | 1.93 K |
| Cash Flow From Operations | (15.05 M) | 971.22 M |
| Short Ratio | 5.43 X | 4.00 X |
| Earnings Per Share | 0.57 X | 3.12 X |
| Target Price | 15.0 | |
| Number Of Employees | 14 | 18.84 K |
| Beta | 0.14 | -0.15 |
| Market Capitalization | 295.78 M | 19.03 B |
| Total Asset | 100.84 M | 29.47 B |
| Retained Earnings | (103.49 M) | 9.33 B |
| Working Capital | 80.54 M | 1.48 B |
| Net Asset | 100.84 M |
Note: Acquisition by Nistala Kiran of 350000 shares of Zura Bio at 3.98 subject to Rule 16b-3 [view details]
Zura Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Zura . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 7210.05 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.95 | |||
| Day Typical Price | 2.94 | |||
| Price Action Indicator | (0.03) | |||
| Relative Strength Index | 51.79 |
About Zura Bio Buy or Sell Advice
When is the right time to buy or sell Zura Bio Limited? Buying financial instruments such as Zura Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Zura Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Zura Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.57 | Return On Assets (0.21) | Return On Equity (0.37) |
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.